SOLV
US EQUITY
Health Care
Health Care Technology
CIK: 1964738
Solventum (SOLV) Quant Factor Diagnostic & Fair Value Model
Solventum (Ticker: SOLV) is listed in the Health Care sector (Health Care Technology). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.
$85.41
-2.33%
Latest Close (2026-10-23)
Market Cap: $14.54B
P/E Ratio: 40.3
Momentum Strength
3M / 12M
+6.14%
1M: -3.59%
12M: +17.39%
Quality (ROE)
Point-in-Time
+7.67%
Trailing Return on Equity
Technical Trend
RSI 14
41.5
SMA50: $88.57
SMA200: $78.38
Valuation Multiplier
Trailing
40.3
Premium Multiple (> 30x P/E)
📊
Valuation & Multi-Factor Diagnostic
Premium Multiple (> 30x P/E)
SOLV trades at 40.3x P/E, reflecting market-implied growth expectations for forward revenue and cash flow.
⚡
Benchmark Factor Strategy
S&P 500 Momentum Alpha Strategy
This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.
📈 Daily Candlestick & Volume Quant Chart
Interactive lightweight price action & volume breakdown over recent 90 trading days.
均线多头 (MA20/50)
Piotroski F-Score: 8/9 (High Financial Strength)
Official Point-in-Time Financial Filing History
Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.
备案 CIK: 1964738 · 10-K 年报 / 10-Q 季报
| Form | Period End | Filing Timestamp (Point-in-Time) | Revenue | Net Income | Operating CF | EPS (Diluted) |
|---|---|---|---|---|---|---|
| 10-Q | 2026-06-30 | 2026-08-05 | $2.21B | $92.00M | $38.00M | $0.53 |
| 10-Q | 2025-12-31 | 2026-08-05 | - | - | - | - |
| 10-Q | 2025-06-30 | 2026-08-05 | $2.16B | $90.00M | $198.00M | $0.51 |
| 10-Q | 2026-03-31 | 2026-05-05 | $2.01B | $13.00M | -$189.00M | $0.07 |
| 10-Q | 2025-03-31 | 2026-05-05 | $2.07B | $137.00M | $29.00M | $0.78 |
| 10-K | 2025-12-31 | 2026-02-27 | $8.32B | $1.56B | $369.00M | $8.88 |
| 10-K | 2024-12-31 | 2026-02-27 | $8.25B | $479.00M | $1.19B | $2.76 |
| 10-K | 2023-12-31 | 2026-02-27 | $8.20B | $1.35B | $1.92B | $7.79 |
💡 Methodology & Frequently Asked Questions
Key reference details regarding Solventum (SOLV) valuation multiples, momentum factors, and point-in-time filing conventions.
How should SOLV's current valuation multiple be interpreted? ↓
SOLV trades at a trailing P/E of 40.3x within the Health Care sector (premium multiple (> 30x p/e)). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.
What are SOLV's key momentum and technical factor indicators? ↓
As of the latest close, SOLV shows a 1-month return of -3.59%, 3-month return of +6.14%, and 12-month return of +17.39%, with a 14-day RSI of 41.5. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.
What is Point-in-Time (PIT) financial data and why does it matter for SOLV? ↓
Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.
How can SOLV be incorporated into systematic factor models? ↓
SOLV can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.